NEWS

Treatment of an unruptured PCOM aneurysm with a flow-diverter stent - Live Case

INR stories: Marc Ribo's uncensored interview

Q’Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neur...

Fremont, CA – January 13, 2025 – Q’Apel Medical (Q’Apel), a privately held medical device company focused on revolutionizing neurovascular interventions, today announced it has received CE mark certification for its Armadillo SelectFlex™ Neurovascular Access System. The first-of-its-kind 7F system features the patented SelectFlex™ Technology and is indicated for the introduction of interventional devices into the neurovasculature.  

Treatment of ruptured MCA aneurysm

Intracranial atherosclerotic disease - Live Case

Treatment of ruptured pericallosal anterior cerebral artery aneurysm

INR stories: Sirintara Pongpech's uncensored interview

Reflecting on 2024: a year of growth and innovation with LINNC online

PCOM rupture embolization with contemporary tetrahedral coil

Webinar Replay - What to expect from the next generation of BGC in acute ischemic stroke treatment?